TAK — TAKEDA PHARMACEUTICAL CO LTD

Ownership history in Squarepoint Ops LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in TAKEDA PHARMACEUTICAL CO LTD (TAK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2020 Q3)
Avg. % of fund
0.0%
First filed
2019 Q1
Last filed
2025 Q3
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 203,810 +159,705 +362.1% 0.00% $3.0M $14.64
2025 Q2 REDUCED 44,105 -19,528 -30.7% 0.00% $682K $15.46
2025 Q1 REDUCED 63,633 -1,041 -1.6% 0.00% $946K $14.87
2024 Q3 REDUCED 64,674 -2,086 -3.1% 0.00% $920K $13.90
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TAK price (monthly, adj. close)

Other funds also holding TAK

As of 2025 Q4 — sorted by position size

MANAGED ASSET PORTFOLIOS, LLC 3Y 7Y 2.82% Clean Yield Group 3Y 7Y 1.13% Legacy Wealth Asset Management, LLC 3Y 0.64% Gold Investment Management Ltd. 0.54% BRANDES INVESTMENT PARTNERS, LP 3Y 7Y 0.46% Carrera Capital Advisors 0.42% Keenan, LLC 0.25% Arjuna Capital 3Y 7Y 0.23% Murphy, Middleton, Hinkle & Parker, Inc. 3Y 7Y 0.23% Corient IA LLC 0.22%
← Back to Squarepoint Ops LLC Holdings